Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. Canada
  4. Toronto Stock Exchange
  5. BriaCell Therapeutics Corp.
  6. News
  7. Summary
    BCT   CA10778Y3023

BRIACELL THERAPEUTICS CORP.

(BCT)
  Report
SummaryQuotesChartsNewsCalendarCompanyFinancialsRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

BriaCell Adds Mary Crowley Cancer Research Center as a Clinical Trial Site For Breast Cancer Study

11/18/2021 | 11:48am EST


ę MT Newswires 2021
All news about BRIACELL THERAPEUTICS CORP.
06:11aBRIACELL THERAPEUTICS : Announces Results of 2022 Annual and Special Meeting of Shareholde..
PU
01/11TMX Group Equity Financing Statistics - December 2021
AQ
01/05BRIACELL THERAPEUTICS : THE ANNUAL GENERAL AND SPECIAL MEETING OF SHAREHOLDERS OF BRIACELL..
PU
2021BRIACELL THERAPEUTICS CORP.(TSXV : BCT) dropped from S&P/TSX Venture Composite Index
CI
2021BRIACELL THERAPEUTICS : to Uplist and Trade on the Toronto Stock Exchange from TSX Venture..
PU
2021BriaCell to List on TSX on Friday
MT
2021BriaCell to Begin Trading on Toronto Stock Exchange
MT
2021BriaCell to Uplist and Trade on the Toronto Stock Exchange from TSX Venture Exchange un..
AQ
2021BRIACELL THERAPEUTICS : Announces Insiders' Intention to Purchase up to 10% of Public Mark..
PU
2021BriaCell Announces Insiders' Intention to Purchase up to 10% of Public Market Securitie..
AQ
More news
Financials (USD)
Sales 2022 - - -
Net income 2022 -12,4 M - -
Net Debt 2022 - - -
P/E ratio 2022 -
Yield 2022 -
Capitalization 129 M 129 M -
Capi. / Sales 2022 -
Capi. / Sales 2023 -
Nbr of Employees 6
Free-Float 74,2%
Chart BRIACELL THERAPEUTICS CORP.
Duration : Period :
BriaCell Therapeutics Corp. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends BRIACELL THERAPEUTICS CORP.
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Managers and Directors
William V. Williams President, Chief Executive Officer & Director
Gadi Levin Chief Financial Officer & Secretary
Jamieson Bondarenko Chairman
Miguel A. Lopez-Lago Senior Director-Research & Development
Rebecca A. Taub Independent Director
Sector and Competitors
1st jan.Capi. (M$)
BRIACELL THERAPEUTICS CORP.-4.31%127
GILEAD SCIENCES, INC.-4.88%86 640
REGENERON PHARMACEUTICALS-2.12%64 627
VERTEX PHARMACEUTICALS5.12%58 692
WUXI APPTEC CO., LTD.-6.39%51 406
BIONTECH SE-37.29%39 044